{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:21:44Z","timestamp":1792801304073,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T00:00:00Z","timestamp":1600819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T00:00:00Z","timestamp":1600819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No.91742205"],"award-info":[{"award-number":["No.91742205"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No.81625004"],"award-info":[{"award-number":["No.81625004"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Beijing Young Scientist Program","award":["BJJWZYJH01201910001006"],"award-info":[{"award-number":["BJJWZYJH01201910001006"]}]},{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","award":["No.2017ZX09304028"],"award-info":[{"award-number":["No.2017ZX09304028"]}],"id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Peking University Clinical Scientist Program by the Fundamental Research Funds for the Central Universities","id":[{"id":"https:\/\/ror.org\/02v51f717","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Acute kidney injury (AKI) is a common clinical disease with complex pathophysiology and limited therapeutic choices. This prompts the need for novel therapy targeting multiple aspects of this disease. Human amnion epithelial cell (hAEC) is an ideal stem cell source. Increasing evidence suggests that exosomes may act as critical cell\u2013cell communicators. Accordingly, we assessed the therapeutic potential of hAECs and their derived exosomes (hAECs-EXO) in ischemia reperfusion mouse model of AKI and explored the underlying mechanisms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The hAECs were primary cultured, and hAECs-EXO were isolated and characterized. An ischemic-reperfusion injury-induced AKI (IRI-AKI) mouse model was established to mimic clinical ischemic kidney injury with different disease severity. Mouse blood creatinine level was used to assess renal function, and kidney specimens were processed to detect cell proliferation, apoptosis, and capillary density. Macrophage infiltration was analyzed by flow cytometry. hAEC-derived exosomes (hAECs-EXO) were used to treat hypoxia-reoxygenation (H\/R) injured HK-2 cells and mouse bone marrow-derived macrophages to evaluate their protective effect in vitro. Furthermore, hAECs-EXO were subjected to liquid chromatography-tandem mass spectrometry for proteomic profiling.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We found that systematically administered hAECs could improve mortality and renal function in IRI-AKI mice, decrease the number of apoptotic cells, prevent peritubular capillary loss, and modulate kidney local immune response. However, hAECs showed very low kidney tissue integration. Exosomes isolated from hAECs recapitulated the renal protective effects of their source cells. In vitro, hAECs-EXO protected HK-2 cells from H\/R injury-induced apoptosis and promoted bone marrow-derived macrophage polarization toward M2 phenotype. Proteomic analysis on hAECs-EXO revealed proteins involved in extracellular matrix organization, growth factor signaling pathways, cytokine production, and immunomodulation. These findings demonstrated that paracrine of exosomes might be the key mechanism of hAECs in alleviating renal ischemia reperfusion injury.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We reported hAECs could improve survival and ameliorate renal injury in mice with IRI-AKI. The anti-apoptotic, pro-angiogenetic, and immunomodulatory capabilities of hAECs are at least partially, through paracrine pathways. hAECs-EXO might be a promising clinical therapeutic tool, overcoming the weaknesses and risks associated with the use of native stem cells, for patients with AKI.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13287-020-01917-y","type":"journal-article","created":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T06:03:09Z","timestamp":1600840989000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":47,"title":["Human amniotic epithelial cells ameliorate kidney damage in ischemia-reperfusion mouse model of acute kidney injury"],"prefix":"10.1186","volume":"11","author":[{"given":"Yifei","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xizi","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suxia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2528-5087","authenticated-orcid":false,"given":"Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,23]]},"reference":[{"issue":"9843","key":"1917_CR1","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/S0140-6736(11)61454-2","volume":"380","author":"R Bellomo","year":"2012","unstructured":"Bellomo R, Kellum JA, Ronco C. Acute kidney injury. Lancet. 2012;380(9843):756\u201366.","journal-title":"Lancet"},{"issue":"4","key":"1917_CR2","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nrneph.2011.16","volume":"7","author":"AA Sharfuddin","year":"2011","unstructured":"Sharfuddin AA, Molitoris BA. Pathophysiology of ischemic acute kidney injury. Nat Rev Nephrol. 2011;7(4):189\u2013200.","journal-title":"Nat Rev Nephrol"},{"issue":"11","key":"1917_CR3","doi-asserted-by":"crossref","first-page":"4210","DOI":"10.1172\/JCI45161","volume":"121","author":"JV Bonventre","year":"2011","unstructured":"Bonventre JV, Yang L. Cellular pathophysiology of ischemic acute kidney injury. J Clin Invest. 2011;121(11):4210\u201321.","journal-title":"J Clin Invest"},{"key":"1917_CR4","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1146\/annurev-med-050214-013407","volume":"67","author":"A Zuk","year":"2016","unstructured":"Zuk A, Bonventre JV. Acute kidney injury. Annu Rev Med. 2016;67:293\u2013307.","journal-title":"Annu Rev Med"},{"issue":"6","key":"1917_CR5","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1172\/JCI72269","volume":"124","author":"BA Molitoris","year":"2014","unstructured":"Molitoris BA. Therapeutic translation in acute kidney injury: the epithelial\/endothelial axis. J Clin Invest. 2014;124(6):2355\u201363.","journal-title":"J Clin Invest"},{"issue":"1\u20132","key":"1917_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00210-007-0183-5","volume":"376","author":"PK Chatterjee","year":"2007","unstructured":"Chatterjee PK. Novel pharmacological approaches to the treatment of renal ischemia-reperfusion injury: a comprehensive review. Naunyn Schmiedeberg\u2019s Arch Pharmacol. 2007;376(1\u20132):1\u201343.","journal-title":"Naunyn Schmiedeberg\u2019s Arch Pharmacol"},{"issue":"1","key":"1917_CR7","first-page":"1","volume":"5","author":"CJ Barnes","year":"2016","unstructured":"Barnes CJ, Distaso CT, Spitz KM, et al. Comparison of stem cell therapies for acute kidney injury. Am J Stem Cells. 2016;5(1):1\u201310.","journal-title":"Am J Stem Cells"},{"issue":"4","key":"1917_CR8","doi-asserted-by":"crossref","first-page":"e13003","DOI":"10.1111\/aji.13003","volume":"80","author":"T Miki","year":"2018","unstructured":"Miki T. Stem cell characteristics and the therapeutic potential of amniotic epithelial cells. Am J Reprod Immunol. 2018;80(4):e13003.","journal-title":"Am J Reprod Immunol"},{"issue":"1","key":"1917_CR9","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jcyt.2013.07.002","volume":"16","author":"A Cargnoni","year":"2014","unstructured":"Cargnoni A, Piccinelli EC, Ressel L, et al. Conditioned medium from amniotic membrane-derived cells prevents lung fibrosis and preserves blood gas exchanges in bleomycin-injured mice-specificity of the effects and insights into possible mechanisms. Cytotherapy. 2014;16(1):17\u201332.","journal-title":"Cytotherapy"},{"issue":"1","key":"1917_CR10","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1006\/exnr.2000.7449","volume":"165","author":"K Kakishita","year":"2000","unstructured":"Kakishita K, Elwan MA, Nakao N, et al. Human amniotic epithelial cells produce dopamine and survive after implantation into the striatum of a rat model of Parkinson's disease: a potential source of donor for transplantation therapy. Exp Neurol. 2000;165(1):27\u201334.","journal-title":"Exp Neurol"},{"issue":"9","key":"1917_CR11","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.3727\/096368910X504496","volume":"19","author":"U Manuelpillai","year":"2010","unstructured":"Manuelpillai U, Tchongue J, Lourensz D, et al. Transplantation of human amnion epithelial cells reduces hepatic fibrosis in immunocompetent CCl4-treated mice [in English]. Cell Transplant. 2010;19(9):1157\u201368.","journal-title":"Cell Transplant"},{"key":"1917_CR12","doi-asserted-by":"crossref","first-page":"A343","DOI":"10.1111\/j.1440-1797.2005.00422.x","volume":"10","author":"F Toegel","year":"2005","unstructured":"Toegel F, Hu ZM, Weiss K, et al. Administered Mesenchymal stem cells protect against ischemic acute renal failure through paracrine and anti-inflammatory mechanisms [in English]. Nephrology. 2005;10:A343\u20134.","journal-title":"Nephrology"},{"issue":"7","key":"1917_CR13","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1172\/JCI22593","volume":"115","author":"JS Duffield","year":"2005","unstructured":"Duffield JS, Park KM, Hsiao LL, et al. Restoration of tubular epithelial cells during repair of the postischemic kidney occurs independently of bone marrow-derived stem cells [in English]. J Clin Invest. 2005;115(7):1743\u201355.","journal-title":"J Clin Invest"},{"issue":"11","key":"1917_CR14","doi-asserted-by":"crossref","first-page":"3791","DOI":"10.1182\/blood.V94.11.3791","volume":"94","author":"HF Heijnen","year":"1999","unstructured":"Heijnen HF, Schiel AE, Fijnheer R, et al. Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules. Blood. 1999;94(11):3791\u20139.","journal-title":"Blood"},{"issue":"8","key":"1917_CR15","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1194\/jlr.E086173","volume":"59","author":"M Record","year":"2018","unstructured":"Record M, Silvente-Poirot S, Poirot M, et al. Extracellular vesicles: lipids as key components of their biogenesis and functions. J Lipid Res. 2018;59(8):1316\u201324.","journal-title":"J Lipid Res"},{"issue":"4","key":"1917_CR16","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.jmb.2015.09.019","volume":"428","author":"S Keerthikumar","year":"2016","unstructured":"Keerthikumar S, Chisanga D, Ariyaratne D, et al. ExoCarta: a web-based compendium of exosomal cargo [in English]. J Mol Biol. 2016;428(4):688\u201392.","journal-title":"J Mol Biol"},{"key":"1917_CR17","first-page":"212a","volume":"64","author":"M Alhomrani","year":"2016","unstructured":"Alhomrani M, Correia J, Hodge A, et al. Extracellular vesicles derived from human amnion epithelial cells reduce liver fibrosis through effects on hepatic stellate cells and macrophages [in English]. Hepatology. 2016;64:212a.","journal-title":"Hepatology"},{"issue":"6","key":"1917_CR18","doi-asserted-by":"publisher","first-page":"909","DOI":"10.3727\/096368910X543385","volume":"20","author":"S Murphy","year":"2011","unstructured":"Murphy S, Lim R, Dickinson H, et al. Human amnion epithelial cells prevent Bleomycin-induced lung injury and preserve lung function [in English]. Cell Transplant. 2011;20(6):909\u201323.","journal-title":"Cell Transplant"},{"key":"1917_CR19","doi-asserted-by":"crossref","unstructured":"Gurunathan S, Kang MH, Jeyaraj M et al. Review of the isolation, characterization, biological function, and multifarious therapeutic approaches of exosomes [in English]. Cells-Basel 2019;8(4):307-43.","DOI":"10.3390\/cells8040307"},{"issue":"12","key":"1917_CR20","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1111\/jcmm.13249","volume":"21","author":"M Gregorini","year":"2017","unstructured":"Gregorini M, Corradetti V, Pattonieri EF, et al. Perfusion of isolated rat kidney with mesenchymal stromal cells\/extracellular vesicles prevents ischaemic injury. J Cell Mol Med. 2017;21(12):3381\u201393.","journal-title":"J Cell Mol Med"},{"issue":"4","key":"1917_CR21","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/ki.2012.105","volume":"82","author":"V Cantaluppi","year":"2012","unstructured":"Cantaluppi V, Gatti S, Medica D, et al. Microvesicles derived from endothelial progenitor cells protect the kidney from ischemia-reperfusion injury by microRNA-dependent reprogramming of resident renal cells [in English]. Kidney Int. 2012;82(4):412\u201327.","journal-title":"Kidney Int"},{"issue":"11","key":"1917_CR22","doi-asserted-by":"crossref","first-page":"F1487","DOI":"10.1152\/ajprenal.00352.2012","volume":"303","author":"Q Wei","year":"2012","unstructured":"Wei Q, Dong Z. Mouse model of ischemic acute kidney injury: technical notes and tricks. Am J Physiol Renal Physiol. 2012;303(11):F1487\u201394.","journal-title":"Am J Physiol Renal Physiol"},{"key":"1917_CR23","doi-asserted-by":"crossref","unstructured":"Jiang HR, Park JH, Kwon GY, et al. Effect of preemptive treatment with human umbilical cord blood-derived mesenchymal stem cells on thedevelopment of renal ischemia-reperfusion injury in mice. Am J Physiol Renal Physiol. 2014;307(10):F1149-1161.","DOI":"10.1152\/ajprenal.00555.2013"},{"key":"1917_CR24","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3389\/fmed.2018.00179","volume":"5","author":"A Torres Crigna","year":"2018","unstructured":"Torres Crigna A, Daniele C, Gamez C, et al. Stem\/stromal cells for treatment of kidney injuries with focus on preclinical models. Front Med (Lausanne). 2018;5:179.","journal-title":"Front Med (Lausanne)"},{"issue":"6","key":"1917_CR25","doi-asserted-by":"crossref","first-page":"F1559","DOI":"10.1152\/ajprenal.00424.2005","volume":"290","author":"K Zahedi","year":"2006","unstructured":"Zahedi K, Revelo MP, Barone S, et al. Stathmin-deficient mice develop fibrosis and show delayed recovery from ischemic-reperfusion injury [in English]. Am J Physiol-Renal. 2006;290(6):F1559\u201367.","journal-title":"Am J Physiol-Renal"},{"key":"1917_CR26","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/978-1-61779-527-5_12","volume":"844","author":"S Manzanero","year":"2012","unstructured":"Manzanero S. Generation of mouse bone marrow-derived macrophages. Methods Mol Biol. 2012;844:177\u201381.","journal-title":"Methods Mol Biol"},{"key":"1917_CR27","doi-asserted-by":"crossref","unstructured":"Grange C, Skovronova R, Marabese F et al. Stem cell-derived extracellular vesicles and kidney regeneration. Cells. 2019;8(10):1240-53.","DOI":"10.3390\/cells8101240"},{"issue":"5","key":"1917_CR28","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1016\/j.jcyt.2018.02.148","volume":"20","author":"W Tseng","year":"2018","unstructured":"Tseng W, Hung S, Chien C, et al. Hypoxia-preconditioned mesenchymal stem cells mitigate renal ischemia-reperfusion injury by modulating M2 macrophage subsets and suppressing oxidative stress [in English]. Cytotherapy. 2018;20(5):S54.","journal-title":"Cytotherapy"},{"key":"1917_CR29","doi-asserted-by":"crossref","unstructured":"Yuan YJ, Li L, Zhu LL, et al. Mesenchymal stem cells elicit macrophages into M2 phenotype via improving transcription factor EB-mediated autophagy to alleviate diabetic nephropathy [in English]. Stem Cells. 2020;38(5):639-52.","DOI":"10.1002\/stem.3144"},{"key":"1917_CR30","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1146\/annurev-physiol-022516-034219","volume":"79","author":"SC Huen","year":"2017","unstructured":"Huen SC, Cantley LG. Macrophages in renal injury and repair. Annu Rev Physiol. 2017;79:449\u201369.","journal-title":"Annu Rev Physiol"},{"issue":"12","key":"1917_CR31","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1111\/1440-1681.12811","volume":"44","author":"JB Zhang","year":"2017","unstructured":"Zhang JB, Wang XQ, Lu GL, et al. Adipose-derived mesenchymal stem cells therapy for acute kidney injury induced by ischemia-reperfusion in a rat model. Clin Exp Pharmacol Physiol. 2017;44(12):1232\u201340.","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"3","key":"1917_CR32","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/scrt469","volume":"5","author":"Y Geng","year":"2014","unstructured":"Geng Y, Zhang L, Fu B, et al. Mesenchymal stem cells ameliorate rhabdomyolysis-induced acute kidney injury via the activation of M2 macrophages. Stem Cell Res Ther. 2014;5(3):80.","journal-title":"Stem Cell Res Ther"},{"issue":"9","key":"1917_CR33","doi-asserted-by":"crossref","first-page":"e46504","DOI":"10.1371\/journal.pone.0046504","volume":"7","author":"TC Fang","year":"2012","unstructured":"Fang TC, Pang CY, Chiu SC, et al. Renoprotective effect of human umbilical cord-derived mesenchymal stem cells in immunodeficient mice suffering from acute kidney injury. PLoS One. 2012;7(9):e46504.","journal-title":"PLoS One"},{"issue":"7","key":"1917_CR34","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1177\/0963689719837897","volume":"28","author":"A Musial-Wysocka","year":"2019","unstructured":"Musial-Wysocka A, Kot M, Majka M. The pros and cons of mesenchymal stem cell-based therapies [in English]. Cell Transplant. 2019;28(7):801\u201312.","journal-title":"Cell Transplant"},{"issue":"4","key":"1917_CR35","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/nrneph.2011.219","volume":"8","author":"DA Long","year":"2012","unstructured":"Long DA, Norman JT, Fine LG. Restoring the renal microvasculature to treat chronic kidney disease [in English]. Nat Rev Nephrol. 2012;8(4):244\u201350.","journal-title":"Nat Rev Nephrol"},{"issue":"11","key":"1917_CR36","doi-asserted-by":"crossref","first-page":"2896","DOI":"10.1634\/stemcells.2007-0637","volume":"25","author":"DG Phinney","year":"2007","unstructured":"Phinney DG, Prockop DJ. Concise review: mesenchymal stem\/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair--current views. Stem Cells. 2007;25(11):2896\u2013902.","journal-title":"Stem Cells"},{"key":"1917_CR37","doi-asserted-by":"crossref","unstructured":"Hur YH, Cerione RA, Antonyak MA. Extracellular vesicles and their roles in stem cell biology [in English]. Stem Cells. 2020;38(4):469-76.","DOI":"10.1002\/stem.3140"},{"key":"1917_CR38","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.omtn.2019.03.008","volume":"16","author":"Q Zhang","year":"2019","unstructured":"Zhang Q, Sun J, Huang Y, et al. Human amniotic epithelial cell-derived exosomes restore ovarian function by transferring microRNAs against apoptosis. Mol Ther Nucleic Acids. 2019;16:407\u201318.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"7","key":"1917_CR39","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1038\/nm.2807","volume":"18","author":"TA Wynn","year":"2012","unstructured":"Wynn TA, Ramalingam TR. Mechanisms of fibrosis: therapeutic translation for fibrotic disease [in English]. Nat Med. 2012;18(7):1028\u201340.","journal-title":"Nat Med"},{"issue":"2","key":"1917_CR40","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/sj.ki.5000054","volume":"69","author":"YH Liu","year":"2006","unstructured":"Liu YH. Renal fibrosis: new insights into the pathogenesis and therapeutics [in English]. Kidney Int. 2006;69(2):213\u20137.","journal-title":"Kidney Int"},{"issue":"3\u20134","key":"1917_CR41","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s12079-009-0069-z","volume":"3","author":"P Bornstein","year":"2009","unstructured":"Bornstein P. Matricellular proteins: an overview [in English]. J Cell Commun Signal. 2009;3(3\u20134):163\u20135.","journal-title":"J Cell Commun Signal"},{"key":"1917_CR42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.matbio.2014.07.005","volume":"37","author":"JE Murphy-Ullrich","year":"2014","unstructured":"Murphy-Ullrich JE, Sage EH. Revisiting the matricellular concept [in English]. Matrix Biol. 2014;37:1\u201314.","journal-title":"Matrix Biol"},{"issue":"11","key":"1917_CR43","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1046\/j.1365-2443.2000.00376.x","volume":"5","author":"T Ikuta","year":"2000","unstructured":"Ikuta T, Ariga H, Matsumoto K. Extracellular matrix tenascin-X in combination with vascular endothelial growth factor B enhances endothelial cell proliferation [in English]. Genes Cells. 2000;5(11):913\u201327.","journal-title":"Genes Cells"},{"issue":"4","key":"1917_CR44","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1159\/000188943","volume":"72","author":"LD Truong","year":"1996","unstructured":"Truong LD, Foster SV, Barrios R, et al. Tenascin is an ubiquitous extracellular matrix protein of human renal interstitium in normal and pathologic conditions [in English]. Nephron. 1996;72(4):579\u201386.","journal-title":"Nephron"},{"issue":"1","key":"1917_CR45","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.kint.2018.08.029","volume":"95","author":"SQ Chen","year":"2019","unstructured":"Chen SQ, Fu HY, Wu SZ, et al. Tenascin-C protects against acute kidney injury by recruiting Wnt ligands [in English]. Kidney Int. 2019;95(1):62\u201374.","journal-title":"Kidney Int"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-020-01917-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-020-01917-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-020-01917-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,22]],"date-time":"2021-09-22T19:27:53Z","timestamp":1632338873000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-020-01917-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,23]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1917"],"URL":"https:\/\/doi.org\/10.1186\/s13287-020-01917-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-28766\/v1","asserted-by":"object"}]},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,23]]},"assertion":[{"value":"11 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Human amniotic epithelial stem cells were isolated by Shanghai iCELL Biotechnology Co Ltd. from fresh amnion membranes collected from healthy mothers after cesarean deliveries in the International Peace Maternity and Child Health Hospital with written and informed consent. The procedure was approved by the Institutional Ethics Committee of the International Peace Maternity and Child Health Hospital, School of Medicine, Shanghai Jiao Tong University (Approval Number: [2014]11).All animal experiments were performed with the approval of the Institutional Animal Care and Use Committee of Peking University First Hospital (Approval Number: J201868).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Li Yang has a patent pending for the use of hAECs in repair of the injured kidney after AKI. Shanghai iCELL Biotechnology company declared no potential conflicts of interest with respect to the research, authorship, and\/or publication of this article. The other authors have no financial conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"410"}}